Fact CheckerSign in

NCT03953014Recruiting

Pharmacogenetics of Antidepressant-Induced Disinhibition

Pharmacogenetics of Antidepressant-Induced Disinhibition in Children Study

Source: ClinicalTrials.gov · Last updated 14 May 2026

Brief summary (registry, in English)

The purpose of this study is to identify pharmacogenetic profiles associated with selective serotonin reuptake inhibitors (SSRI)-induced behavioral disinhibition in children with Major depressive disorder (MDD), anxiety disorders and/or obsessive-compulsive disorder (OCD) that could be used clinically to reduce the incidence of this adverse event and improve health outcomes.

Status (registry)
Recruiting
Study type
Observational
Enrollment
120 (estimated)
First submitted
14 May 2019
Start date
2 Jan 2019
Primary completion date
30 Sept 2026
Lead sponsor
University of Calgary
Diseases
Depression
NCT number
NCT03953014

What you commit to

  • Study type: Observational
  • Planned participants: 120
  • From 2 Jan 2019 to the primary completion date, 30 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Current, past or suspected diagnosis of attention deficit hyperactivity disorder, oppositional defiant disorder, conduct disorder, bipolar disorder, psychotic disorder, or pervasive developmental disorder.

Other

  • Inability of parent/legal guardian to give informed consent
  • Inability of the child to give informed assent
  • Unwillingness of child to provide saliva sample for genetic analysis

Who the study is looking for

  • Aged 6 - 24 years
  • Medical records available
  • Diagnosis of MDD, anxiety disorder, or OCD
  • Current or past history of SSRI therapy

Age in the registry: 6 years to 17 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Child and Adolescent Addiction, Mental Health & Psychiatry
Coordinator of this site? Confirm its status
CalgaryCanadaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.